As healthcare providers, our understanding of neurodegenerative disorders is continually evolving, and Parkinson's Disease (PD) is no exception. This article provides a comprehensive overview of PD, its pathophysiology, clinical manifestations, diagnosis, and treatment options.
PD is primarily characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to an imbalance in the dopaminergic and cholinergic systems. The accumulation of α-synuclein, forming Lewy bodies, is a significant hallmark of the disease.
PD presents a range of motor symptoms such as bradykinesia, rigidity, and tremors. Non-motor symptoms like cognitive impairment, mood disorders, and autonomic dysfunction are also prevalent. The disease progression varies significantly among patients.
Diagnosis is primarily clinical, based on patient history and neurological examination. Currently, no definitive diagnostic test exists for PD; however, neuroimaging techniques like DaTSCAN can support the diagnosis.
Treatment for PD is symptomatic and aims to manage motor and non-motor symptoms. Levodopa remains the most effective treatment for motor symptoms. Deep Brain Stimulation (DBS) is another treatment modality for patients with advanced PD.
Research is ongoing to develop disease-modifying therapies for PD. These include neuroprotective agents, immunotherapies targeting α-synuclein, and regenerative therapies like stem cell transplantation.
PD is a complex neurodegenerative disorder with a multifaceted clinical presentation. Understanding its pathophysiology, clinical manifestations, and treatment options is crucial for providing comprehensive care. As medical professionals, we must stay abreast of the latest research to effectively manage and potentially alter the course of this debilitating disease.
1.
Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'
2.
Renewing the call for a national Cancer Patient's Bill of Rights
3.
Woman Loses 6-Year Battle With Mouth Tumor
4.
Pressing the Sleep button could have a positive impact on cognition.
5.
FDA Approves Iberdomide Combo for Multiple Myeloma
1.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
2.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
3.
Polycythemia Vera: A Historical Perspective and Contemporary Management
4.
ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring
5.
Prevention Through Survivorship-Focused Strategies for Preserving Functional Independence After Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
The Role of Platelets in Normal Blood Clotting
4.
Comprehensive Update on Hematology
5.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation